l General Information |
Product Name | Allopurinol Sodium |
General description | Allopurinol Sodium is a xanthine oxidase inhibitor with an IC50 of 7.82 ± 0.12 μM. |
Synonym | sodium;1H-pyrazolo[3,4-d]pyrimidin-4-olate |
Purity | ≥98.0%(HPLC) | CAS Number | 17795-21-0 |
Formula | C5H3N4NaO | Molecular Weight | 158.096 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥25mg/ml |
Ethanol | Insoluble |
Water | ≥25mg/ml |
l Biological Information |
Biochem/Physiol
Actions | Allopurinol Sodium is the sodium form of allopurinol, which is a structural isomer of hypoxanthine. Allopurinol inhibits xanthine oxidase, an enzyme that converts oxypurines to uric acid. By blocking the production of uric acid, this agent decreases serum and urine concentrations of uric acid, thereby providing protection against uric acid-mediated end organ damage in conditions associated with excessive production of uric acid, i.e. the massive cell lysis associated with the treatment of some malignancies. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
